Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-042407
Filing Date
2024-10-24
Accepted
2024-10-24 17:18:37
Documents
16
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 78155
2 ex31-1.htm EX-31.1 13027
3 ex31-2.htm EX-31.2 12838
  Complete submission text file 0001493152-24-042407.txt   377557

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pwup-20240331.xsd EX-101.SCH 4290
5 XBRL DEFINITION FILE pwup-20240331_def.xml EX-101.DEF 31658
6 XBRL LABEL FILE pwup-20240331_lab.xml EX-101.LAB 39348
7 XBRL PRESENTATION FILE pwup-20240331_pre.xml EX-101.PRE 28669
18 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 12080
Mailing Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038
Business Address 1200 BROADWAY, FLOOR 3 NEW YORK NY 10038 561-704-8527
PowerUp Acquisition Corp. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41293 | Film No.: 241393484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)